Bovine Hemoglobin
Authors:
- 6 August 2012
- journal article
- case report
- Published by SAGE Publications in Journal of Pharmacy Practice
- Vol. 26 (3) , 257-260
Abstract
Introduction: Management of severe symptomatic anemia in critically ill Jehovah’s Witness patients remains a challenge. The paucity of therapeutic alternatives to human red blood cells has prompted the use of blood substitutes. Case Report: A 19-year-old female Jehovah’s Witness patient presented to the emergency department following several episodes of syncope. She was found to have a positive Coombs test and was diagnosed with warm-bodied autoimmune hemolytic anemia. Upon admission, her hemoglobin was 8.4 g/dL, then dropped to a nadir of 2.8 g/dL 4 days later. She received traditional management with corticosteroids, intravenous immune globulin, rituximab, and partial splenic artery embolization. Despite these therapies, hemoglobin levels failed to respond, and she experienced signs of marked ischemia. A decision was made to give 2 units of Hemopure, a bovine hemoglobin-based oxygen carrier, and the hemoglobin levels increased to 8.7 g/dL 10 days later. The patient’s overall clinical condition improved leading to subsequent hospital discharge. Conclusion: This case exemplifies the ingenuity that health care practitioners must use in critical situations involving the medical management of anemic Jehovah’s Witness patients who refuse blood products. Hemopure was used as “bridging treatment” to help save a patient from the devastating effects of ischemia resulting from severe anemia.Keywords
This publication has 14 references indexed in Scilit:
- Management of acute anemia in a Jehovah's Witness patient with acute lymphoblastic leukemia with polymerized bovine hemoglobin‐based oxygen carrier: a case report and review of literatureTransfusion, 2010
- When Blood Is Not an Option: Factors Affecting Survival After the Use of a Hemoglobin-Based Oxygen Carrier in 54 Patients with Life-Threatening AnemiaAnesthesia & Analgesia, 2010
- HBOC-201 as an Alternative to Blood Transfusion: Efficacy and Safety Evaluation in a Multicenter Phase III Trial in Elective Orthopedic SurgeryJournal of Trauma: Injury, Infection & Critical Care, 2008
- Epidemiology of autoimmune diseases in DenmarkJournal of Autoimmunity, 2007
- Autoimmune hemolytic anemiaAmerican Journal of Hematology, 2002
- Treatment of autoimmune hemolytic anemiasCurrent Opinion in Hematology, 2001
- Recent developments in hemoglobin-based oxygen carriers – an update on clinical trialsTransfusion and Apheresis Science, 2001
- Transfusions of Polymerized Bovine Hemoglobin in a Patient with Severe Autoimmune Hemolytic AnemiaNew England Journal of Medicine, 2000
- Physiology and pharmacokinetics of a novel hemoglobin-based oxygen carrier in humansCritical Care Medicine, 1996
- Haemoglobin‐Based Red Cell Substitutes: Current StatusVox Sanguinis, 1995